Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Barton Hutt currently holds 33,027 shares of Q Therapeutics, Inc. ([NONE]), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Barton Hutt has been a net seller of [NONE] stock. They have purchased $0 and sold $8.0M worth of shares.
Peter Barton Hutt's most recent insider trade was on Mar 6, 2023, when they sold 16,400 shares at $0.00 per share.
Peter Barton Hutt serves as Executive at Q Therapeutics, Inc. ([NONE]). They have executed 36 insider transactions totaling $8.0M over their tenure at the company.
Peter Barton Hutt holds the position of Executive at Q Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Peter Barton Hutt has shown a selling trading pattern, with $0 in total purchases and $8.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Peter Barton Hutt was on Nov 20, 2019, when they sold $4.0M worth of MRNA shares. This transaction involved 200,000 shares at $20.18 per share.
Peter Barton Hutt currently owns 33,027 shares of Q Therapeutics, Inc. ([NONE]), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Barton Hutt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Barton Hutt has 36 Form 4 filings on record as an insider at Q Therapeutics, Inc..
Set alerts for Peter Barton Hutt and 40,000+ other insiders.